Targeting Myeloma Stem Cells with T Cells Armed with Anti-CD3 X Anti-CD20 Bispecific Antibody (CD20BI) Prior to ASCT Leads to Development of Anti-Myeloma Immune Responses Post Autologous Stem Cell Transplant That Can Be Boosted with Targeted T Cells

Saved in:
Bibliographic Details
Published in:Biology of blood and marrow transplantation 2012, Vol.18 (2), p.S259-S259
Main Authors: Lawrence, L.G, Archana, T, Muneer, A, Zaid, A.-K, Voravit, R, Jeffrey, Z, Lois, A, Elyse, P.N, Dana, S, Patricia, S.A, Karen, M, Joseph, U.P
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2011.12.162